Symbol="XENE"
AssetType="Common Stock"
Name="Xenon Pharmaceuticals Inc"
Description="Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada."
CIK="1582313"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 - 3650 GILMORE WAY, BURNABY, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2279980000"
EBITDA="-159223008"
PERatio="None"
PEGRatio="-0.06"
BookValue="10.88"
DividendPerShare="0"
DividendYield="0"
EPS="-2.35"
RevenuePerShareTTM="0.011"
ProfitMargin="0"
OperatingMarginTTM="-240.76"
ReturnOnAssetsTTM="-0.157"
ReturnOnEquityTTM="-0.24"
RevenueTTM="668000"
GrossProfitTTM="-96333000"
DilutedEPSTTM="-2.35"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="52.31"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="181.44"
PriceToBookRatio="3.217"
EVToRevenue="136.05"
EVToEBITDA="-16.41"
Beta="1.399"
num_52WeekHigh="43.75"
num_52WeekLow="31.14"
num_50DayMovingAverage="39.84"
num_200DayMovingAverage="37.75"
SharesOutstanding="63562000"
DividendDate="None"
ExDividendDate="None"
symbol="XENE"
open="35.85"
high="36.13"
low="35.26"
price="35.83"
volume="297702.00"
latest_trading_day="2023-07-27"
previous_close="35.80"
change="0.03"
change_percent="0.0838%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="43"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="361884"
Change_recent_avg="0.01"
Delta_recent_avg="1.39"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="169"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_negative_thumbnail_id_2="161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="577"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_positive_thumbnail_id_1="964"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_positive_thumbnail_id_2="1015"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
